Studies have shown that GLP-1 agonists can trigger effects in the brain, the heart, the liver, the pancreas, the stomach, and the musclesmeaning that they could have implications for conditions other than type 2 diabetes and obesity, such as heart disease, kidney disease, liver disease, and even neurological conditions such as Alzheimer's disease
Vision Plan Coverage Documents CareFirst BlueVision Plus offers a national network of optometrists, ophthalmologists and opticians
Excess body fat can affect hormone production, so weight loss from GLP-1 medications may improve some hormonal imbalances related to carrying extra weight
At Laser Lipo and Veins Center, were here to walk with you every step of the wayfrom FDA changes to lifestyle shifts, from semaglutide to liposuction and beyond
Hepatology 56 , 21542162 (2012)